Sequenom (NASDAQ: SQNM) is a manufacturer of DNA massarrays, based in San Diego, California. The MassARRAY platform is used for SNP genotyping, methylation detection and quantitative gene expression analysis. Sequenom's wholly owned subsidiarity, Sequenom Center for Molecular Medicine (SCMM), also offers clinical molecular genetics testing, such as MaterniT21 PLUS, a noninvasive prenatal test for trisomy 21, trisomy 18, and trisomy 13, RetnaGene AMD a genetic test for risk of progression for age-related macular degeneration, Heredi-T Cystic Fibrosis Screening Test, and the SensiGene Fetal RHD Genotyping Test.
Read more about Sequenom: Competition, Patent Litigation, SEQureDx Scandal, MaterniT21 PLUS, MassARRAY Analyzer 4, IPLEX ADME PGx Panel On MassARRAY System